Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 18851-18900 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT02673320
Prospective Study for Delay in Surgical Treatment of Traumatic Cervical Central Cord Injury in Canal Stenosis
NAActive, not recruiting
72 participants
Started: Jul 31, 2016 · Completed: Jul 31, 2027
1 condition1 sponsor5 locations
NCT02481635
A Study of Gemcitabine/Nab-paclitaxel and Radiation Therapy Followed by Surgery in Patients With Advanced Pancreatic Cancer
PHASE1/PHASE2Active, not recruiting
30 participants
Started: Jul 31, 2016 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT03015064
Post-Myocardial Infarction Patients in Santa Catarina, Brazil - Catarina Heart Study
N/AActive, not recruiting
1,426 participants
Started: Jul 31, 2016 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT02882685
Comparison of Mini Gastric Bypass and Roux-en-Y Gastric Bypass
NAActive, not recruiting
120 participants
Started: Jul 31, 2016 · Completed: Dec 31, 2026
1 condition1 sponsor2 locations
NCT02936453
STIMO: Epidural Electrical Simulation (EES) With Robot-assisted Rehabilitation in Patients With Spinal Cord Injury.
NAActive, not recruiting
10 participants
Started: Jul 31, 2016 · Completed: Jul 31, 2026
1 condition3 sponsors1 location
NCT03955510
Abnormal Food Timing and Circadian Dyssynchrony in Alcohol Induced Colon Carcinogenesis
NAActive, not recruiting
12 participants
Started: Jul 31, 2016 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT02825264
STAR-LIFE Registry: STARflo Glaucoma Implant Clinical Experience Program
N/AActive, not recruiting
70 participants
Started: Jul 31, 2016 · Completed: Dec 31, 2026
1 condition1 sponsor9 locations
NCT02555072
Immunity Period After One Dose of Yellow Fever Vaccine in Adults and Children (Paraiba Study)
PHASE4Active, not recruiting
4,761 participants
Started: Jul 31, 2016 · Completed: Dec 31, 2027
2 conditions2 sponsors6 locations
NCT02789956
Internal vs. External Connection in Screw-retained Multi-units Bridges With Cad/Cam Milled Co/Cr Framework (ISUS-Atlantis)
NAActive, not recruiting
48 participants
Started: Jul 31, 2016 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT02811588
HomeVent ( Connect) Registry: EU COPD Home NIV Registry
N/AActive, not recruiting
169 participants
Started: Jul 31, 2016 · Completed: Jun 30, 2025
1 condition2 sponsors4 locations
NCT02477878
Study of Gene Modified Donor T Cell Infusion in Patients With Recurrent Disease After Allogeneic Transplant
PHASE1Active, not recruiting
10 participants
Started: Jul 31, 2016 · Completed: Jan 31, 2033
5 conditions1 sponsor5 locations
NCT02728635
Epigenetic Regulation of Human Adipose Tissue Distribution
NAActive, not recruiting
27 participants
Started: Jul 31, 2016 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT02828618
Trial on Radical Upfront Surgery in Advanced Ovarian Cancer
NAActive, not recruiting
797 participants
Started: Jul 31, 2016 · Completed: Dec 31, 2025
1 condition1 sponsor20 locations
NCT02656706
Adjuvant Nivolumab & Low Dose Ipilimumab for Stage III & Resected Stage IV Melanoma
PHASE2Active, not recruiting
22 participants
Started: Jul 31, 2016 · Completed: Jul 31, 2025
1 condition3 sponsors1 location
NCT02739711
Glycoprotein IIb/IIIa Inhibitors Versus Standard Therapy in Patients with Myocardial Infarction and No-reflow
PHASE4Active, not recruiting
120 participants
Started: Jul 31, 2016 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT02737449
CorEvitas Japan Rheumatoid Arthritis (RA) Registry
N/AActive, not recruiting
2,000 participants
Started: Jul 31, 2016 · Completed: Dec 31, 2100
1 condition1 sponsor0 locations
NCT02623400
The Effect of Perinatal Stress on the Development of Preterm Infants
N/AActive, not recruiting
174 participants
Started: Jul 31, 2016 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT02661503
HD21 for Advanced Stages
PHASE3Active, not recruiting
1,500 participants
Started: Jul 31, 2016 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT02991924
Risk Factors of Medistinal Metastasis in Endoscopic Staging of Lung Cancer
N/AActive, not recruiting
600 participants
Started: Jul 31, 2016 · Completed: Jul 31, 2026
1 condition5 sponsors1 location
NCT02846987
Study of Abemaciclib in Dedifferentiated Liposarcoma
PHASE2Active, not recruiting
33 participants
Started: Jul 31, 2016 · Completed: Jul 31, 2026
2 conditions2 sponsors1 location
NCT02687906
Dose-finding, Pharmacokinetics, and Safety of VABOMERE in Pediatric Subjects With Bacterial Infections
PHASE1Active, not recruiting
39 participants
Started: Jul 31, 2016 · Completed: Dec 31, 2025
1 condition2 sponsors9 locations
NCT02284308
Elderly With Locally Advanced Lung Cancer: Deciding Through Geriatric Assessment on the Optimal Treatment Strategy
N/AActive, not recruiting
180 participants
Started: Jul 31, 2016 · Completed: Dec 18, 2029
1 condition6 sponsors22 locations
NCT03461497
Development of a Patient-Reported Outcome Measure to Assess Recovery After Abdominal Surgery
N/AActive, not recruiting
530 participants
Started: Jul 31, 2016 · Completed: Jul 31, 2026
1 condition7 sponsors7 locations
NCT02783664
Evaluating the Effects of Genetic Testing on Patients' Stress Levels
N/AActive, not recruiting
164 participants
Started: Jul 31, 2016 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT02849223
Transcranial Direct Current Stimulation (TDCS) as an Intervention for Patients With Traumatic Brain Injury
PHASE2Active, not recruiting
41 participants
Started: Jul 31, 2016 · Completed: Sep 30, 2026
1 condition3 sponsors1 location
NCT02743910
Monitoring Plasma Tumor DNA in Early-Stage Breast Cancer
N/AActive, not recruiting
229 participants
Started: Jul 31, 2016 · Completed: Jul 31, 2026
1 condition2 sponsors1 location
NCT02728076
MRI-Based Preoperative Accelerated Partial Breast Irradiation
NAActive, not recruiting
39 participants
Started: Jul 29, 2016 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT04084145
National Unified Renal Translation Research Enterprise - Chronic Kidney Disease
N/AActive, not recruiting
3,004 participants
Started: Jul 27, 2016 · Completed: Dec 31, 2032
1 condition11 sponsors2 locations
NCT02843425
The Beans to Enrich the Gut Microbiome vs. Obesity's Negative Effects (BE GONE) Trial
NAActive, not recruiting
71 participants
Started: Jul 25, 2016 · Completed: Apr 1, 2027
1 condition1 sponsor1 location
NCT02842619
Filling Bone Defects/Voids With Autologous BonoFill-II for Maxillofacial Bone Regeneration
PHASE1/PHASE2Active, not recruiting
27 participants
Started: Jul 23, 2016 · Completed: Dec 30, 2025
2 conditions1 sponsor1 location
NCT02595944
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
PHASE3Active, not recruiting
903 participants
Started: Jul 22, 2016 · Completed: Dec 31, 2026
3 conditions1 sponsor888 locations
NCT02595931
M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
PHASE1Active, not recruiting
66 participants
Started: Jul 22, 2016 · Completed: Mar 6, 2026
18 conditions1 sponsor23 locations
NCT03519074
Cisplatin Combined with Oral TS-1 in Patients with Advanced Solid Tumors with Different Degrees of Liver Dysfunction
PHASE2Active, not recruiting
48 participants
Started: Jul 22, 2016 · Completed: Dec 20, 2025
2 conditions1 sponsor2 locations
NCT03877276
Dietary Oxalate and Immune Cell Function
NAActive, not recruiting
82 participants
Started: Jul 21, 2016 · Completed: Dec 1, 2027
1 condition1 sponsor1 location
NCT02719106
IRIS Ultimaster Cohort in the IRIS-DES Registry
N/AActive, not recruiting
1,000 participants
Started: Jul 20, 2016 · Completed: Jul 24, 2024
1 condition2 sponsors15 locations
NCT02603887
Pembrolizumab in Treating Patients With Intermediate or High-Risk Smoldering Multiple Myeloma
EARLY_PHASE1Active, not recruiting
20 participants
Started: Jul 20, 2016 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT02698254
Radiation Therapy in Treating Patients With Recurrent Brain Tumors Who Have Undergone Previous Radiation Therapy
NAActive, not recruiting
40 participants
Started: Jul 20, 2016 · Completed: Jul 31, 2027
1 condition2 sponsors1 location
NCT02489006
A Study of Olaparib Prior to Surgery and Chemotherapy in Ovarian, Primary Peritoneal, and Fallopian Tube Cancer
PHASE2Active, not recruiting
71 participants
Started: Jul 19, 2016 · Completed: Dec 31, 2025
4 conditions1 sponsor9 locations
NCT02642042
Trametinib and Docetaxel in Treating Patients With Recurrent or Stage IV KRAS Mutation Positive Non-small Cell Lung Cancer
PHASE2Active, not recruiting
60 participants
Started: Jul 18, 2016 · Completed: Mar 19, 2026
3 conditions1 sponsor601 locations
NCT02743741
Lu-DOTATATE Treatment in Patients With 68Ga-DOTATATE Somatostatin Receptor Positive Neuroendocrine Tumors
NAActive, not recruiting
195 participants
Started: Jul 15, 2016 · Completed: Jun 30, 2026
1 condition4 sponsors4 locations
NCT02827877
Cu64-DOTA-trastuzumab PET and Markers Predicting Response to Neoadjuvant Trastuzumab + Pertuzum in HER2+ Breast Cancer
PHASE2Active, not recruiting
18 participants
Started: Jul 15, 2016 · Completed: Oct 16, 2025
4 conditions2 sponsors1 location
NCT02719613
Continuing Treatment for Participants Who Have Participated in a Prior Protocol Investigating Elotuzumab
PHASE2Active, not recruiting
67 participants
Started: Jul 15, 2016 · Completed: Nov 13, 2025
1 condition2 sponsors41 locations
NCT02790515
Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation
PHASE2Active, not recruiting
170 participants
Started: Jul 14, 2016 · Completed: Jul 1, 2026
7 conditions1 sponsor1 location
NCT02632305
A Study to See the Effects That a New Combination of the Three Drugs, Nab-paclitaxel, Gemcitabine, and Cisplatin Has on Biliary Tract Cancer
PHASE2Active, not recruiting
45 participants
Started: Jul 13, 2016 · Completed: Dec 31, 2026
1 condition2 sponsors2 locations
NCT02917798
Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient Outcomes
N/AActive, not recruiting
1,047 participants
Started: Jul 12, 2016 · Completed: Sep 30, 2026
3 conditions2 sponsors5 locations
NCT02761070
Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase III
PHASE3Active, not recruiting
146 participants
Started: Jul 11, 2016 · Completed: Nov 10, 2025
3 conditions2 sponsors37 locations
NCT02655016
A Study of Niraparib (GSK3985771) Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy
PHASE3Active, not recruiting
733 participants
Started: Jul 11, 2016 · Completed: Jan 30, 2026
1 condition4 sponsors200 locations
NCT02756897
Venetoclax and Ibrutinib in Treating Patients With Chronic or Small Lymphocytic Leukemia
PHASE2Active, not recruiting
234 participants
Started: Jul 7, 2016 · Completed: Jul 1, 2027
6 conditions1 sponsor1 location
NCT05709730
Follow-up of Cell Changes in the Cervix
N/AActive, not recruiting
885 participants
Started: Jul 7, 2016 · Completed: Dec 1, 2029
1 condition1 sponsor1 location
NCT02769520
Efficacy Study of Pembrolizumab in Relapsed, Locally Recurrent Squamous Cell Cancer of the Head and Neck
PHASE2Active, not recruiting
27 participants
Started: Jul 6, 2016 · Completed: Apr 30, 2026
1 condition2 sponsors3 locations